Michael Dunn sells multiple stakes under 10b5-1 plan (SYM)
Rhea-AI Filing Summary
Michael Dunn reported multiple 10b5-1 sales of Common Stock under Form 144, executed through Morgan Stanley Smith Barney LLC. The filing lists sales on 02/25/2026 (4,274 shares, $240,684.33), 02/24/2026 (15,040 shares, $841,087.94), 02/11/2026 (2,593 shares, $152,311.78), 01/28/2026 (3,051 shares, $168,128.71), 01/26/2026 (8,470 shares, $509,091.89), 01/14/2026 (1,363 shares, $93,883.44), 12/31/2025 (1,012 shares, $60,689.64), and 12/17/2025 (1,190 shares, $74,601.10).
The sales are identified as 10b5-1 plan transactions in the filing and were processed through Morgan Stanley Smith Barney LLC; timing and plan status are disclosed alongside each sale date.
Positive
- None.
Negative
- None.
Insights
Multiple routine 10b5-1 dispositions were reported by Michael Dunn across late 2025–early 2026.
The filing lists specific sale dates and per-sale share counts with dollar amounts processed through Morgan Stanley Smith Barney LLC. Each row in the excerpt identifies the transactions as 10b5-1 Sales, which indicates they were executed under a prearranged trading plan.
Compliance considerations hinge on plan documentation and windows; subsequent filings or plan disclosures would clarify whether sales followed an active 10b5-1 schedule. Cash‑flow treatment is the reported proceeds per sale in the excerpt.